Price data may be delayed — our pipeline hasn't confirmed a fresh update recently. Figures shown could be from an earlier session.
MCIMCI Capital Alternatywna Spólka Inwestycyjna S.A.
28.20PLN-2.42%Mkt Cap: 374.67M $P/E: 43.38

MCI Capital Alternatywna Spólka Inwestycyjna S.A., is a private equity and venture capital firm specializing in seed/startup, early to late venture, buy-out, middle market, mature, emerging growth, and growth capital inv…

HeadlineSourceTime
Older
Bankier.pl
BBIZNES24
Bankier.pl
wnp.pl
SStrefa Inwestorów
BBIZNES24
Heineken’s Strongbow adds NaviLens levels to packaging

The cider brand has added a high-contrast NaviLens QR code to its cans.

Packaging Gateway
3 firms to lay off hundreds of North Jersey-based employees

BioReference health, JPMorgan Chase and an Italian fashion retailer are making the job cuts amid market uncertainty

The Bergen Record
Novartis to acquire Tourmaline Bio for $1.4 billion

Novartis will acquire Tourmaline Bio for $48 per share, valuing the New York-based biopharmaceutical company at $1.4 billion on a fully diluted basis, the Swiss pharma giant said on Tuesday. Tourmaline is focused on developing pacibekitug, a promising targeted therapy with the potential to reduce systemic inflammation, as a treatment option for atherosclerotic cardiovascular disease, Novartis said in a statement. With the deal, Novartis will acquire a Phase III-ready asset that will complement its existing cardiovascular disease portfolio, it said.

Reuters
SStowarzyszenie Inwestorów Indywidualnych
MMiesięcznik Finansowy BANK
PParkiet